Independent cohort studies further demonstrated that the PNPLA3 rs738409 variant confers increased risk of NASH, fibrosis, and hepatocellular carcinoma (HCC) [12,13]. This evidence concerns the gene PNPLA3 and hepatocellular carcinoma.